))
Journal Club: COMPASS Psilocybin Phase 2 Results
Manage episode 375676847 series 3507121
Konten disediakan oleh Psychedelic Brain Science. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Psychedelic Brain Science atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Join Alaina and Zarmeen this week as they celebrate Zarmeen's birthday by diving into the recently published report of a phase 2 clinical trial of psilocybin for treatment resistant depression. They go over some background, methodology and results surrounding the study and what it means moving forward. Of course, they also give their interpretations and discuss thoughts about sensationalism, limitations and the things they liked about the study.
CW: suicidal ideation and self-injury.
The content of YBOS is the opinion of the authors and does not reflect the opinion of others or author affiliations.
56 episode
Bagikan
